Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Effect of Digitally Supported Medical Nutrition Therapy on Left Ventricular Ejection Fraction in Patients With ST-Elevation Myocardial Infarction

NCT07427199 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-12-30
Last updated
2026-02-23

Condition(s) studied

ST-elevation Myocardial Infarction (STEMI)

Investigational drug(s) / intervention(s)

Digital Content-Supported Medical Nutrition Therapy

Digital Content-Supported Medical Nutrition Therapy: Participants receive a personalized medical nutrition therapy program supported by digital content. The program includes educational materials, meal planning guides, and remote support. The intervention lasts 3 months, with follow-up visits at baseline, 1 month, and 3 months. Heart function (LVEF) will be measured at each time point.

Study summary

This study is designed to investigate the effect of a nutrition program supported by digital content on heart function in patients who have experienced a heart attack with ST-elevation. Participants will receive personalized dietary guidance and digital support materials for three months. The main goal is to determine whether this digital support materials can improve heart pumping function (measured by left ventricular ejection fraction). Participation involves following the dietary program and undergoing heart function measurements at the beginning, after one months and after three months.

Eligibility

Sex
ALL
Min age
19 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Individuals aged 19-65 who have fully completed the voluntary consent form * Being of normal weight (BMI 18.5-24.9 kg/m²) or obese (30-34.99 kg/m²) * Having suffered a heart attack with ST elevation (STEMI) * To be enrolled in the study within the first 72 hours after hospital admission * To be willing to participate in a follow-up period of at least 3 months Exclusion Criteria: * Those who did not sign the voluntary consent form * Individuals aged over 65 * Weight loss exceeding 5% in the last 3 months * Those with malignancy, chronic renal failure or severe systemic disease * Patients unable to complete the questionnaires due to severe cognitive impairment * Those who have previously received nutrition education or eating awareness training

Primary outcome measure(s)

  • Left Ventricular Ejection Fraction (LVEF) — Baseline, 1 month, 3 months
    Left ventricular ejection fraction will be measured using echocardiography at baseline, 1 month, and 3 months to evaluate the effect of digital content-supported medical nutrition therapy.

Trial sites (1)

FacilityCityRegionStatus
Ondokuz Mayıs Üniversitesi Tıp Fakültesi Hastanesi Samsun Atakum Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07427199 on ClinicalTrials.gov ↗ ← All trials in Turkey